Skip to main content
Erschienen in: European Radiology 7/2019

08.04.2019 | Imaging Informatics and Artificial Intelligence

Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study

verfasst von: He Zhang, Yunfei Mao, Xiaojun Chen, Guoqing Wu, Xuefen Liu, Peng Zhang, Yu Bai, Pengcong Lu, Weigen Yao, Yuanyuan Wang, Jinhua Yu, Guofu Zhang

Erschienen in: European Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the ability of MRI radiomics to categorize ovarian masses and to determine the association between MRI radiomics and survival among ovarian epithelial cancer (OEC) patients.

Method

A total of 286 patients with pathologically proven adnexal tumor were retrospectively included in this study. We evaluated diagnostic performance of the signatures derived from MRI radiomics in differentiating (1) between benign adnexal tumors and malignancies and (2) between type I and type II OEC. The least absolute shrinkage and selection operator method was used for radiomics feature selection. Risk scores were calculated from the Lasso model and were used for survival analysis.

Result

For the classification between benign and malignant masses, the MRI radiomics model achieved a high accuracy of 0.90 in the leave-one-out (LOO) cross-validation cohort and an accuracy of 0.87 in the independent validation cohort. For the classification between type I and type II subtypes, our method made a satisfactory classification in the LOO cross-validation cohort (accuracy = 0.93) and in the independent validation cohort (accuracy = 0.84). Low-high-high short-run high gray-level emphasis and low-low-high variance from coronal T2-weighted imaging (T2WI) and eccentricity from axial T1-weighted imaging (T1WI) images had the best performance in two classification tasks. The patients with higher risk scores were more likely to have poor prognosis (hazard ratio = 4.1694, p = 0.001).

Conclusion

Our results suggest radiomics features extracted from MRI are highly correlated with OEC classification and prognosis of patients. MRI radiomics can provide survival estimations with high accuracy.

Key Points

• The MRI radiomics model could achieve a higher accuracy in discriminating benign ovarian diseases from malignancies.
• Low-high-high short-run high gray-level emphasis, low-low-high variance from coronal T2WI, and eccentricity from axial T1WI had the best performance outcomes in various classification tasks.
• The ovarian cancer patients with high-risk scores had poor prognosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chen WZR, Baade PD, Zhang S et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRefPubMed Chen WZR, Baade PD, Zhang S et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRefPubMed
3.
Zurück zum Zitat Bowtell DD, Böhm S, Ahmed AA et al (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15:668–679CrossRefPubMedPubMedCentral Bowtell DD, Böhm S, Ahmed AA et al (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15:668–679CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31:625–646CrossRefPubMed Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31:625–646CrossRefPubMed
6.
Zurück zum Zitat Medeiros LR, Freitas LB, Rosa DD et al (2011) Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review. Am J Obstet Gynecol 204:67–e1CrossRefPubMed Medeiros LR, Freitas LB, Rosa DD et al (2011) Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review. Am J Obstet Gynecol 204:67–e1CrossRefPubMed
7.
Zurück zum Zitat Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587CrossRefPubMed Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587CrossRefPubMed
8.
Zurück zum Zitat Li W, Chu C, Cui Y, Zhang P, Zhu M (2012) Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37:897–903CrossRefPubMed Li W, Chu C, Cui Y, Zhang P, Zhu M (2012) Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37:897–903CrossRefPubMed
9.
Zurück zum Zitat Mitchell CL, O'Connor JPB, Jackson A et al (2010) Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy. Ann Oncol 21:1982–1989CrossRefPubMed Mitchell CL, O'Connor JPB, Jackson A et al (2010) Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy. Ann Oncol 21:1982–1989CrossRefPubMed
10.
Zurück zum Zitat Zhang H, Zhang G-F, He Z-Y, Li Z-Y, Zhang G-X (2014) Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis. Arch Gynecol Obstet 289:357–364CrossRefPubMed Zhang H, Zhang G-F, He Z-Y, Li Z-Y, Zhang G-X (2014) Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis. Arch Gynecol Obstet 289:357–364CrossRefPubMed
11.
Zurück zum Zitat Thomassin-Naggara I, Balvay D, Aubert E et al (2012) Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 22:738–745CrossRefPubMed Thomassin-Naggara I, Balvay D, Aubert E et al (2012) Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 22:738–745CrossRefPubMed
12.
Zurück zum Zitat Stein EB, Wasnik AP, Sciallis AP, Kamaya A, Maturen KE (2017) MR imaging–pathologic correlation in ovarian cancer. Magn Reson Imaging Clin N Am 25:545–562CrossRefPubMed Stein EB, Wasnik AP, Sciallis AP, Kamaya A, Maturen KE (2017) MR imaging–pathologic correlation in ovarian cancer. Magn Reson Imaging Clin N Am 25:545–562CrossRefPubMed
13.
Zurück zum Zitat Alcázar JL, Utrilla-Layna J, Mínguez JÁ, Jurado M (2013) Clinical and ultrasound features of type I and type II epithelial ovarian cancer. Int J Gynecol Cancer 23:680–684CrossRefPubMed Alcázar JL, Utrilla-Layna J, Mínguez JÁ, Jurado M (2013) Clinical and ultrasound features of type I and type II epithelial ovarian cancer. Int J Gynecol Cancer 23:680–684CrossRefPubMed
14.
Zurück zum Zitat Prahm KP, Karlsen MA, Høgdall E et al (2015) The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics. Gynecol Oncol 136:205–211CrossRefPubMed Prahm KP, Karlsen MA, Høgdall E et al (2015) The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics. Gynecol Oncol 136:205–211CrossRefPubMed
15.
Zurück zum Zitat Tang H, Liu Y, Wang X et al (2018) Clear cell carcinoma of the ovary: clinicopathologic features and outcomes in a Chinese cohort. Medicine (Baltimore) 97:e10881 Tang H, Liu Y, Wang X et al (2018) Clear cell carcinoma of the ovary: clinicopathologic features and outcomes in a Chinese cohort. Medicine (Baltimore) 97:e10881
16.
Zurück zum Zitat Lee JY, Kim S, Kim YT et al (2018) Changes in ovarian cancer survival during the 20 years before the era of targeted therapy. BMC Cancer 18:601 Lee JY, Kim S, Kim YT et al (2018) Changes in ovarian cancer survival during the 20 years before the era of targeted therapy. BMC Cancer 18:601
17.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
18.
Zurück zum Zitat Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749CrossRefPubMed Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749CrossRefPubMed
19.
Zurück zum Zitat Anastasi E, Gigli S, Ballesio L, Angeloni A, Manganaro L (2018) The complementary role of imaging and tumor biomarkers in gynecological cancers: an update of the literature. Asian Pac J Cancer Prev 19:309–317PubMedPubMedCentral Anastasi E, Gigli S, Ballesio L, Angeloni A, Manganaro L (2018) The complementary role of imaging and tumor biomarkers in gynecological cancers: an update of the literature. Asian Pac J Cancer Prev 19:309–317PubMedPubMedCentral
20.
Zurück zum Zitat Rajkotia K, Veeramani M, Macura KJ (2006) Magnetic resonance imaging of adnexal masses. Top Magn Reson Imaging 17:379–397CrossRefPubMed Rajkotia K, Veeramani M, Macura KJ (2006) Magnetic resonance imaging of adnexal masses. Top Magn Reson Imaging 17:379–397CrossRefPubMed
21.
Zurück zum Zitat Thomassin-Naggara I, Daraï E, Cuenod CA, Rouzier R, Callard P, Bazot M (2008) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 28:111–120CrossRefPubMed Thomassin-Naggara I, Daraï E, Cuenod CA, Rouzier R, Callard P, Bazot M (2008) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 28:111–120CrossRefPubMed
22.
Zurück zum Zitat Ortiz-Ramón R, Larroza A, Ruiz-España S, Arana E, Moratal D (2018) Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study. Eur Radiol 28:4514–4523CrossRefPubMed Ortiz-Ramón R, Larroza A, Ruiz-España S, Arana E, Moratal D (2018) Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study. Eur Radiol 28:4514–4523CrossRefPubMed
23.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006 Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006
24.
Zurück zum Zitat Yu J, Shi Z, Lian Y et al (2017) Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol 27:3509–3522CrossRefPubMed Yu J, Shi Z, Lian Y et al (2017) Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol 27:3509–3522CrossRefPubMed
25.
Zurück zum Zitat Wu G, Chen Y, Wang Y et al (2018) Sparse representation-based radiomics for the diagnosis of brain tumors. IEEE Trans Med Imaging 37:893–905CrossRefPubMed Wu G, Chen Y, Wang Y et al (2018) Sparse representation-based radiomics for the diagnosis of brain tumors. IEEE Trans Med Imaging 37:893–905CrossRefPubMed
26.
Zurück zum Zitat Li H, Zhu Y, Burnside ES et al (2016) Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer 2:16012 Li H, Zhu Y, Burnside ES et al (2016) Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer 2:16012
28.
Zurück zum Zitat Meng Y, Zhang Y, Dong D et al (2018) Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer. J Magn Reson Imaging 48:605–614 Meng Y, Zhang Y, Dong D et al (2018) Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer. J Magn Reson Imaging 48:605–614
29.
Zurück zum Zitat Zhu X, Dong D, Chen Z et al (2018) Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer. Eur Radiol 28:2772–2778 Zhu X, Dong D, Chen Z et al (2018) Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer. Eur Radiol 28:2772–2778
30.
Zurück zum Zitat Ferreira Junior JR, Koenigkam-Santos M, Cipriano FEG, Fabro AT, Azevedo-Marques PM (2018) Radiomics-based features for pattern recognition of lung cancer histopathology and metastases. Comput Methods Programs Biomed 159:23–30 Ferreira Junior JR, Koenigkam-Santos M, Cipriano FEG, Fabro AT, Azevedo-Marques PM (2018) Radiomics-based features for pattern recognition of lung cancer histopathology and metastases. Comput Methods Programs Biomed 159:23–30
31.
Zurück zum Zitat Lindgren A, Anttila M, Rautiainen S et al (2017) Primary and metastatic ovarian cancer: characterization by 3.0T diffusion-weighted MRI. Eur Radiol 27:4002–4012CrossRefPubMedPubMedCentral Lindgren A, Anttila M, Rautiainen S et al (2017) Primary and metastatic ovarian cancer: characterization by 3.0T diffusion-weighted MRI. Eur Radiol 27:4002–4012CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Wang F, Wang Y, Zhou Y (2017) Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models. J Magn Reson Imaging 46:1797–1809 Wang F, Wang Y, Zhou Y (2017) Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models. J Magn Reson Imaging 46:1797–1809
33.
Zurück zum Zitat Rizzo S, Botta F, Raimondi S et al (2018) Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months. Eur Radiol 28:4849–4859CrossRefPubMed Rizzo S, Botta F, Raimondi S et al (2018) Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months. Eur Radiol 28:4849–4859CrossRefPubMed
34.
Zurück zum Zitat Qiu Y, Tan M, McMeekin S et al (2016) Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis. Acta Radiol 57:1149–1155CrossRefPubMed Qiu Y, Tan M, McMeekin S et al (2016) Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis. Acta Radiol 57:1149–1155CrossRefPubMed
35.
Zurück zum Zitat Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJ (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5:13087 Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJ (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5:13087
36.
Zurück zum Zitat Liu Y, Zhang Y, Cheng R et al (2019) Radiomics analysis of apparent diffusion coefficient in cervical cancer: a preliminary study on histological grade evaluation. J Magn Reson Imaging 49:280–290 Liu Y, Zhang Y, Cheng R et al (2019) Radiomics analysis of apparent diffusion coefficient in cervical cancer: a preliminary study on histological grade evaluation. J Magn Reson Imaging 49:280–290
37.
Zurück zum Zitat Ueno Y, Forghani B, Forghani R et al (2017) Endometrial carcinoma: MR imaging–based texture model for preoperative risk stratification—a preliminary analysis. Radiology 284:748–757CrossRefPubMed Ueno Y, Forghani B, Forghani R et al (2017) Endometrial carcinoma: MR imaging–based texture model for preoperative risk stratification—a preliminary analysis. Radiology 284:748–757CrossRefPubMed
38.
Zurück zum Zitat Marth C, Reimer D, Zeimet AG (2017) Front-line therapy of advanced epithelial ovarian cancer: standard treatment. Ann Oncol 28:viii36–viii39CrossRefPubMed Marth C, Reimer D, Zeimet AG (2017) Front-line therapy of advanced epithelial ovarian cancer: standard treatment. Ann Oncol 28:viii36–viii39CrossRefPubMed
39.
Zurück zum Zitat Nakamura K, Joja I, Nagasaka T et al (2012) The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence. Gynecol Oncol 127:478–483CrossRefPubMed Nakamura K, Joja I, Nagasaka T et al (2012) The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence. Gynecol Oncol 127:478–483CrossRefPubMed
40.
Zurück zum Zitat Schob S, Meyer HJ, Pazaitis N et al (2017) ADC histogram analysis of cervical cancer aids detecting lymphatic metastases—a preliminary study. Mol Imaging Biol 19:953–962CrossRefPubMed Schob S, Meyer HJ, Pazaitis N et al (2017) ADC histogram analysis of cervical cancer aids detecting lymphatic metastases—a preliminary study. Mol Imaging Biol 19:953–962CrossRefPubMed
41.
Zurück zum Zitat Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed
42.
Zurück zum Zitat Vasquez MM, Hu C, Roe DJ, Chen Z, Halonen M, Guerra S (2016) Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol 16:154CrossRefPubMedPubMedCentral Vasquez MM, Hu C, Roe DJ, Chen Z, Halonen M, Guerra S (2016) Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol 16:154CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Huang Y, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. Jpn J Clin Oncol 34:2157–2164 Huang Y, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. Jpn J Clin Oncol 34:2157–2164
Metadaten
Titel
Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study
verfasst von
He Zhang
Yunfei Mao
Xiaojun Chen
Guoqing Wu
Xuefen Liu
Peng Zhang
Yu Bai
Pengcong Lu
Weigen Yao
Yuanyuan Wang
Jinhua Yu
Guofu Zhang
Publikationsdatum
08.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06124-9

Weitere Artikel der Ausgabe 7/2019

European Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.